Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease.

Ahn TB, Langston JW, Aachi VR, Dickson DW.

Am J Neurodegener Dis. 2012;1(1):49-59. Epub 2012 Apr 18.

2.

Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.

Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H.

Brain Pathol. 2008 Jul;18(3):415-22. doi: 10.1111/j.1750-3639.2008.00140.x. Epub 2008 Apr 2.

PMID:
18394008
4.

Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Dugger BN, Dickson DW.

Acta Neuropathol. 2010 Nov;120(5):633-9. doi: 10.1007/s00401-010-0739-1. Epub 2010 Aug 19.

5.

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T.

Am J Pathol. 1998 Apr;152(4):879-84.

6.

Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.

Hishikawa N, Hashizume Y, Ujihira N, Okada Y, Yoshida M, Sobue G.

Neuropathol Appl Neurobiol. 2003 Jun;29(3):280-7.

PMID:
12787325
7.

[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].

Iwatsubo T.

Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6. Japanese.

PMID:
10791099
8.

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O'Connell B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ.

Am J Pathol. 1998 Nov;153(5):1365-70.

9.

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.

Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.

Brain Res. 1999 Oct 2;843(1-2):53-61.

PMID:
10528110
10.

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M.

Acta Neuropathol. 2000 Sep;100(3):285-90.

PMID:
10965798
11.

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.

Wakabayashi K, Tanji K, Mori F, Takahashi H.

Neuropathology. 2007 Oct;27(5):494-506. Review.

PMID:
18018486
12.

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Jellinger KA.

Acta Neuropathol. 2003 Sep;106(3):191-201. Epub 2003 Jul 5. Erratum in: Acta Neuropathol (Berl). 2003 Dec;106(6):588.

PMID:
12845452
13.

Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology.

Rüb U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, Braak H.

Neurobiol Aging. 2002 Mar-Apr;23(2):245-54.

PMID:
11804710
14.

[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].

Wakabayashi K.

Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. Review. Japanese.

PMID:
19198138
15.

Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects.

Shehadeh L, Mitsi G, Adi N, Bishopric N, Papapetropoulos S.

Mov Disord. 2009 Jan 30;24(2):204-10. doi: 10.1002/mds.22306.

PMID:
18951507
16.

Evidence in favor of Braak staging of Parkinson's disease.

Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y.

Mov Disord. 2010;25 Suppl 1:S78-82. doi: 10.1002/mds.22637.

PMID:
20187227
17.
18.

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?

Olanow CW, Brundin P.

Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Review.

PMID:
23390095
19.

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice.

Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S, Sondel J, Kotilinek L, Day J, Schwarzschild MA, Cha JH, Newell K, Miller DW, Uéda K, Young AB, Hyman BT, Ashe KH.

Neurobiol Aging. 2003 Mar-Apr;24(2):245-58.

PMID:
12498958
20.

Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.

Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW.

J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97.

PMID:
12722831

Supplemental Content

Support Center